Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Anti-melanin antibodies are increased in sera in Parkinson's disease.

Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Riederer P, Gerlach M, Halliday GM.

Exp Neurol. 2009 Jun;217(2):297-301. doi: 10.1016/j.expneurol.2009.03.002. Epub 2009 Mar 13.

PMID:
19289120
2.

p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.

Mogi M, Kondo T, Mizuno Y, Nagatsu T.

Neurosci Lett. 2007 Feb 27;414(1):94-7. Epub 2006 Dec 29.

PMID:
17196747
3.

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.

Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J.

Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x. Epub 2008 May 7.

PMID:
18462474
4.

Anti-GM1 ganglioside antibodies in Parkinson's disease.

Zappia M, Crescibene L, Bosco D, Arabia G, Nicoletti G, Bagalà A, Bastone L, Napoli ID, Caracciolo M, Bonavita S, Di Costanzo A, Gambardella A, Quattrone A.

Acta Neurol Scand. 2002 Jul;106(1):54-7.

PMID:
12067330
5.

Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease.

Fiszer U, Fredrikson S, Członkowska A.

J Neurol Sci. 1996 Jul;139(1):66-70.

PMID:
8836974
6.

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM.

Neurology. 2007 May 22;68(21):1820-5.

PMID:
17515544
7.
8.

Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.

Ferrer I, Perez E, Dalfó E, Barrachina M.

Neurosci Lett. 2007 Mar 30;415(3):205-9. Epub 2007 Jan 14.

PMID:
17284347
9.

Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

Knott C, Stern G, Wilkin GP.

Mol Cell Neurosci. 2000 Dec;16(6):724-39.

PMID:
11124893
10.
11.

Circulating interleukin-10 and interleukin-12 in Parkinson's disease.

Rentzos M, Nikolaou C, Andreadou E, Paraskevas GP, Rombos A, Zoga M, Tsoutsou A, Boufidou F, Kapaki E, Vassilopoulos D.

Acta Neurol Scand. 2009 May;119(5):332-7. doi: 10.1111/j.1600-0404.2008.01103.x. Epub 2008 Oct 23.

PMID:
18976327
12.

Excessive dopamine neuron loss in progressive supranuclear palsy.

Murphy KE, Karaconji T, Hardman CD, Halliday GM.

Mov Disord. 2008 Mar 15;23(4):607-10. doi: 10.1002/mds.21907.

PMID:
18163454
13.

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C.

Arch Neurol. 2006 Apr;63(4):584-8.

PMID:
16606773
14.

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC.

J Neurochem. 2003 Sep;86(5):1142-8.

15.

The progression of Parkinson disease: a hypothesis.

Lang AE.

Neurology. 2007 Mar 20;68(12):948-52.

PMID:
17372132
16.

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH.

Neurobiol Dis. 2009 Sep;35(3):385-98. doi: 10.1016/j.nbd.2009.05.023. Epub 2009 Jun 6.

PMID:
19505575
17.

[Methods for the early diagnosis of Parkinson's disease].

Becker G.

Nervenarzt. 2003 Mar;74 Suppl 1:S7-11. German.

PMID:
12624678
18.

Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.

Gerlach M, Riederer P, Double KL.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S185-8. doi: 10.1016/j.parkreldis.2008.04.028. Epub 2008 Jun 27. Review.

PMID:
18585086
19.

The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non-neurological diseases.

Fiszer U, Tomik B, Grzesiowski P, Krygowska-Wajs A, Walory J, Michałowska M, Palasik W.

Acta Neurol Scand. 2004 Aug;110(2):113-7.

PMID:
15242419
20.

The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.

Lee FK, Wong AK, Lee YW, Wan OW, Chan HY, Chung KK.

J Neurochem. 2009 Jul;110(1):208-19. doi: 10.1111/j.1471-4159.2009.06124.x. Epub 2009 Apr 27.

Supplemental Content

Support Center